Dr. Kai Dittmann is currently the Medical Lead for Hematology & Rare Diseases at Roche, having previously held roles including Medical Manager for Hemophilia Emicizumab and Medical Group Lead for Neuroscience. Dr. Dittmann completed a PhD in Cellular and Molecular Immunology at Georg-August-University Goettingen, graduating summa cum laude. Prior to this, they were a PhD candidate at the University of Bielefeld and earned degrees in Laboratory Chemistry and Biochemistry. Dr. Dittmann gained valuable experience as a postdoctoral scientist at the University Medical Center Goettingen from 2005 to 2007.
This person is not in the org chart
This person is not in any teams
This person is not in any offices